Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-PedersenDepartment of Cardiology, Bispebjerg University Hospital, Copenhagen, DenmarkAbstract: Beta-blockers have been shown to improve survival in patients with chronic heart failure. The effect of different generations of...
Main Authors: | Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2007-03-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/carvedilol-in-the-treatment-of-chronic-heart-failure-lessons-from-the--peer-reviewed-article-VHRM |
Similar Items
-
Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
by: Køber Lars, et al.
Published: (2011-10-01) -
Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study
by: Raunsø Jakob, et al.
Published: (2010-05-01) -
Metoprolol vs carvedilol in heart failure
by: Norton Michael, et al.
Published: (2000-10-01) -
A comparison of the mechanisms of action of carvedilol and metoprolol in chronic heart failure
by: McClure, Samuel J.
Published: (2008) -
Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
by: S. Serge Barold, et al.
Published: (2018-01-01)